Medication info

Wybleu Injection

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCopper Sulfate›1.57mg / 1mLManganese Sulfate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
YouYoung Pharmaceutical Co., Ltd.
Appearance
A colorless, transparent vial injection containing a colorless, transparent solution that is odorless or light blue.
Packaging
10mL × 10 vials
Approval status
Active

MFDS item code 201704493 · Notified 2017.06.20

Summary

Main use
Improvement of micronutrient (zinc, copper, etc.) nutrition during intravenous nutritional support
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and check plasma trace element levels to guide dose adjustment. Permitted dosage range (intravenous): Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4㎎ daily Copper: 0.5∼1.5㎎ daily Manganese: 0.15∼0.8㎎ daily Chromium: 10∼15㎍ daily Selenium: 20∼40㎍ daily Patients with small intestinal fluid losses who are metabolically stable: Additional 12.2㎎/L (volume of small intestinal fluid lost) or 17.1㎎/㎏ (stool output) Patients with acute catabolic conditions: 4.5∼6㎎ daily Patients with small intestinal fluid losses who are metabolically stable: 20㎍ daily Deficiency due to long-term parenteral nutrition: 100㎍ daily may be used for 24∼31 days.
Child administration
Age 5 years and under: Zinc 100㎍ per ㎏ body weight daily, copper 20㎍ per ㎏ body weight daily, manganese 2∼10㎍ per ㎏ body weight daily, chromium 0.14∼0.20㎍ per ㎏ body weight daily, selenium 3㎍ per ㎏ body weight daily

Ingredients

Manufacturer
YouYoung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of micronutrient (zinc, copper, etc.) nutrition during intravenous nutritional support

View approved original text

This helps support metabolic functions in the body and maintain normal physiological functions by appropriately supplementing trace elements such as zinc, copper, manganese, selenium, and chromium during intravenous nutrition administration. These trace elements promote immune strength and tissue recovery and are essential for the activation of various enzymes. Thus, it prevents nutritional imbalances or deficiencies and contributes to the overall improvement of the patient's health status.

How it is given

Adult administration

Use as prescribed by a physician, and check plasma trace element levels to guide dose adjustment. Permitted dosage range (intravenous): Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4㎎ daily Copper: 0.5∼1.5㎎ daily Manganese: 0.15∼0.8㎎ daily Chromium: 10∼15㎍ daily Selenium: 20∼40㎍ daily Patients with small intestinal fluid losses who are metabolically stable: Additional 12.2㎎/L (volume of small intestinal fluid lost) or 17.1㎎/㎏ (stool output) Patients with acute catabolic conditions: 4.5∼6㎎ daily Patients with small intestinal fluid losses who are metabolically stable: 20㎍ daily Deficiency due to long-term parenteral nutrition: 100㎍ daily may be used for 24∼31 days.

Child administration

Age 5 years and under: Zinc 100㎍ per ㎏ body weight daily, copper 20㎍ per ㎏ body weight daily, manganese 2∼10㎍ per ㎏ body weight daily, chromium 0.14∼0.20㎍ per ㎏ body weight daily, selenium 3㎍ per ㎏ body weight daily

Precautions

This medication may cause fatal respiratory issues due to benzyl alcohol when used in premature infants, so caution is necessary. Direct intravenous injection in an undiluted state can cause phlebitis, so it must be diluted before use. Being a hypotonic solution, it should only be used in mixed injections and should not be administered as a single component. If any toxic reactions occur from any of the ingredients, administration must be stopped immediately. Aluminum included in non-oral nutritional fluids may cause toxicity with prolonged administration in patients with impaired renal function, especially in premature infants, hence must be used cautiously. Benzyl alcohol should not be administered to neonates and premature infants due to its content. Although trace elements such as zinc, copper, manganese, chromium, and selenium are present in small amounts, toxic symptoms are generally not apparent at normal doses. Before administration, the patient's condition and metabolic requirements must be accurately assessed, and blood trace element levels should be frequently tested to adjust dosages. Patients with renal impairment should be careful as zinc may accumulate in the body, and patients with biliary obstruction are at risk of copper and manganese accumulation. Chromium is excreted through the kidneys, and for diabetic patients, interactions with blood glucose control medications should be considered. Selenium dosage needs to be adjusted in patients with renal and gastrointestinal dysfunction, and in transfusion patients, transfusion effects should be taken into account. The safety of this medication during pregnancy has not been established, so it should only be used in pregnant women or women of childbearing potential when the therapeutic benefits outweigh the risks. Overdose may lead to toxicity symptoms of trace elements such as zinc, copper, chromium, and selenium, so the dosage must be strictly adhered to. In particular, excessive zinc intake may cause serious side effects such as hypotension, pulmonary edema, and decreased consciousness, while excessive copper intake may result in collapse, diarrhea, and hypotension. Excessive selenium intake may cause hair loss, dermatitis, gastrointestinal disturbances, and in severe cases, can lead to coma, so caution is warranted. When using this medication, it must be prepared in a sterile condition under a physician’s prescription, and the solution must be checked for discoloration or foreign substances before administration. Store in a dry place at room temperature, out of reach of children. Transferring to other containers may result in quality degradation or accident risk, hence it must be stored in its original packaging.

Side effects

  • Shortness of breath
  • sweating
  • decreased consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • hyperamylasemia
  • hypotension
  • pulmonary edema
  • diarrhea
Show 31 more
  • vomiting
  • jaundice
  • decreased urine output
  • fatigue
  • behavioral changes
  • progressive wasting
  • photophobia
  • peripheral edema
  • nausea
  • ulcer
  • gastrointestinal disturbances
  • renal impairment
  • hepatic impairment
  • seizures
  • coma
  • alopecia
  • nail weakness
  • dermatitis
  • dental damage
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlic odor during breathing
  • acute peripheral vascular collapse
  • vascular congestion
  • pulmonary hemorrhage
  • pulmonary congestion
  • pulmonary edema
  • gastric mucosal discoloration
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air ingress and kept in a cool place between 15 to 30 degrees Celsius. This storage condition helps maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

A colorless, transparent vial injection containing a colorless, transparent solution that is odorless or light blue.

Package unit

10mL × 10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.